USANA HEALTH SCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
USANA HEALTH SCIENCES, INC. (USNA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $4.94 million for the 12-month period ending 2019-12-28, per its 10-K filed 2020-02-25.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2020-02-25
- USANA HEALTH SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2016-01-02 was $7.78M, a 77.55% decline year-over-year.
- USANA HEALTH SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2015-10-03 was $12.73M, a 367.77% increase year-over-year.
- USANA HEALTH SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2015-07-04 was $17.69M, a 132.65% increase year-over-year.
- USANA HEALTH SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2015-04-04 was $3.35M, a 50.81% decline year-over-year.
- USANA HEALTH SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2019 was $4.94M, a 89.32% decline from fiscal 2018.
- USANA HEALTH SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2018 was $46.22M, a 81.81% increase from fiscal 2017.
- USANA HEALTH SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2017 was $25.42M, a 33.44% decline from fiscal 2016.
- USANA HEALTH SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2016 was $38.20M, a 8.06% decline from fiscal 2016.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month |
|---|---|---|---|---|
| 2019-12-28 | $4.94M 10-K · filed 2020-02-25 | |||
| 2018-12-29 | $46.22M 10-K · filed 2020-02-25 | |||
| 2017-12-30 | $25.42M 10-K · filed 2020-02-25 | |||
| 2016-12-31 | $38.20M 10-K · filed 2019-02-26 | |||
| 2016-01-02 | $7.78M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $20.51M derived: sum of 2 quarters · filed 2018-02-28 | $38.20M derived: sum of 3 quarters · filed 2018-02-28 | $41.55M 10-K · filed 2018-02-28 |
| 2015-10-03 | $12.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $30.42M derived: sum of 2 quarters · filed 2015-11-12 | $33.76M 10-Q · filed 2015-11-12 | $68.43M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-07-04 | $17.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $21.04M 10-Q · filed 2015-08-12 | $55.71M derived: sum of 3 quarters · filed 2017-03-01 | $58.43M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-04-04 | $3.35M 10-Q · filed 2015-05-13 | $38.02M derived: sum of 2 quarters · filed 2017-03-01 | $40.74M derived: sum of 3 quarters · filed 2017-03-01 | $48.34M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-01-03 | $34.67M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $37.39M derived: sum of 2 quarters · filed 2017-03-01 | $44.99M derived: sum of 3 quarters · filed 2017-03-01 | $51.80M 10-K · filed 2017-03-01 |
| 2014-09-27 | $2.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $10.32M derived: sum of 2 quarters · filed 2015-11-12 | $17.13M 10-Q · filed 2015-11-12 | $18.93M derived: sum of 4 quarters · filed 2016-03-01 |
| 2014-06-28 | $7.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $14.40M 10-Q · filed 2015-08-12 | $16.21M derived: sum of 3 quarters · filed 2016-03-01 | $36.81M derived: sum of 4 quarters · filed 2016-03-01 |
| 2014-03-29 | $6.80M 10-Q · filed 2015-05-13 | $8.61M derived: sum of 2 quarters · filed 2016-03-01 | $29.21M derived: sum of 3 quarters · filed 2016-03-01 | $38.49M derived: sum of 4 quarters · filed 2016-03-01 |
| 2013-12-28 | $1.81M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-01 | $22.41M derived: sum of 2 quarters · filed 2016-03-01 | $31.69M derived: sum of 3 quarters · filed 2016-03-01 | $32.84M 10-K · filed 2016-03-01 |
| 2013-09-28 | $20.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $29.88M derived: sum of 2 quarters · filed 2014-11-06 | $31.03M 10-Q · filed 2014-11-06 | |
| 2013-06-29 | $9.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $10.43M 10-Q · filed 2014-08-05 | ||
| 2013-03-30 | $1.15M 10-Q · filed 2014-05-07 | |||
| 2012-12-29 | $20.59M 10-K · filed 2015-03-17 | |||
| 2011-12-31 | $925.00K 10-K · filed 2014-03-13 | |||
| 2011-01-01 | $16.98M 10-K · filed 2013-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |